The Indian markets are witnessing a flurry of developments across multiple sectors, with pharma, credit cards, and real estate grabbing investor attention. Pharma Sector: Event-Driven MomentumSignificant activity continues in the pharma space, with Glenmark Pharma advancing its oncology portfolio, Dr Reddy’s partnering with Hetero for an HIV prevention drug, and Lupin receiving approvals for its … Read more
Mumbai: HDFC Asset Management Company, Bosch, Muthoot Finance, Cummins India, Polycab India, Dixon Technologies, Swiggy and Canara Bank are likely to be upgraded from mid-cap to large-cap in the next Association of Mutual Fund in India’s semi-annual reclassification in January 2026, according to Nuvama Alternative & Quantitative Research. The mutual fund industry body announces the … Read more
Rupak De, Senior Technical Analyst at LKP Securities, sees Nifty sustaining its short-term uptrend as long as it holds above 24,800, with potential to climb towards 25,000–25,250. While Bank Nifty remains weak, he highlights UNO Minda and Lupin as bullish picks for the week, alongside a sell call on Axis Bank. Edited excerpts from a … Read more
“For disclosure, HUL and Asian Paints have been my top picks since the beginning of this year, and I have mentioned this on your channel before. The slowdown in consumption had been so severe that a recovery was inevitable at some point. First, we had income tax rates being revised upwards, leaving more money in … Read more
Sandeep Tandon, CIO, Quant Mutual Fund, expresses strong confidence in India’s decoupling process, highlighting Asia-centric emerging markets‘ advantageous position over developed economies, evidenced by currency movements. He identifies the pharmaceutical sector as a prime beneficiary in the current economic climate. Tandon advocates for investing in pharma funds, deeming it a highly promising and straightforward investment … Read more
India’s largest life insurer Life Insurance Corporation (LIC), two-wheeler major Hero MotoCorp and pharma stocks like Novartis, Zydus Lifesciences and Lupin will be among 25 companies which will be holding their record dates for the purpose of dividend. Check if you own any of these stocks: Monday, July 21 It will be the ex-date and … Read more
Brokerages remain bullish on select BSE mid-capstocks across sectors. According to Trendlyne data, 10 stocks—including Dixon Technologies, Aurobindo Pharma, Crompton Greaves Consumer Electricals, and Ipca Laboratories—have received strong analyst ratings and are projected to deliver returns of up to45%. Here’s the list: Source link
Mutual fund investment has become an appealing opportunity for wealth accumulation. A key advantage of this investment avenue is its accessibility, as individuals can start investing with amounts as low as Rs 100 or Rs 200 through Systematic Investment Plans (SIPs). The power of compound interest, given time to grow, has the potential to turn … Read more
BSE Midcap index has produced 12 gems since last Diwali, each delivering multibagger returns with 26 others yielding double-digit returns of 50% or more. There are 19 duds as well in the pack of 192 stocks which have fallen by up to 50% during this period. The 12 multibaggers are Indian Renewable Energy Development Agency … Read more
“I think the broader call one will have to take only post getting the clarity on the earnings picture. But my overall view is that the Nifty or the largecap companies by and large should hold out. I do not see a reason for a significant downward correction as far as the Nifty and the … Read more